Table 1.
Baseline characteristics of patients assigned to the BSS plus® or Z-Celcoat™ group
| BSS plus® group | Z-Celcoat™ group | P-value | |
|---|---|---|---|
| Number of eyes | 97 (53%) | 86 (47%) | 0.460 |
| Age (years) | 73±6.0 | 73±6.5 | 0.435 |
| Sex (male/female) | 42/55 (43%/57%) | 22/64 (26%/74%) | 0.012a |
| Number of diabetic patients | 4 (4.1%) | 7 (8.1%) | 0.273 |
| Patients taking tamsulosine | 8 (8.2%) | 6 (7%) | 0.933 |
| Corneal endothelium cell density (ECD) (cells/mm2) | 2,506±310 | 2,433±261 | 0.107 |
| Average size of corneal endothelium cell (µm2) (ECS) | 406±57 | 416±50 | 0.097 |
| Anterior chamber depth (ACD) (mm) | 3.3±0.43 | 3.24±0.43 | 0.243 |
Notes:
a
Significant differences between both groups. Data are represented as mean ± standard deviation unless otherwise stated.
Abbreviations: BSS, balanced salt solution; ECS, endothelium cell size.